Tirzepatide (Mounjaro) wins FDA approval for type 2 diabetes
To learn how the GLP-1 hormone works, see: What Is GLP-1
The obesity epidemic continues to affect millions of Americans, with approximately two-thirds of the population classified as overweight or obese.[1] Individuals who are overweight or have obesity are more likely to develop type 2 diabetes (T2D), though not everyone with excess weight develops the condition.[2] For non-diabetics seeking support with weight loss, semaglutide has gained significant attention
Highest pharmacy standards Every batch verified Expert oversight Hear from people who began peptide therapy with questions and moved forward with clarity, confidence, and clinically guided care
Blood thinners and easy bruising belong in provider conversations If you take blood thinners, have a bleeding disorder, bruise easily, or have been told to watch for bleeding, discuss injection bruising with your healthcare provider
The pharmacy should process it like a secondary insurance
